MED20
Mediator of RNA polymerase II transcription subunit 20
Also known as: DKFZp586D2223, MED20_HUMAN, PRO0213, SRB2, TRFP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H944
- Gene
- MED20
- Ensembl
- ENSG00000124641
- Chromosome
- 6
- Canonical length
- 212 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a component of the mediator complex (also known as TRAP, SMCC, DRIP, or ARC), a transcriptional coactivator complex thought to be required for the expression of almost all genes. The mediator complex is recruited by transcriptional activators or nuclear receptors to induce gene expression, by interacting with RNA polymerase II and promoting the formation of a transcriptional pre-initiation complex. A mutation in this gene has been associated with a novel infantile-onset neurodegenerative movement disorder. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Mar 2015]
Canonical amino-acid sequenceUniProt
212 residues, UniProt reviewed canonical sequence.
>Q9H944|MED20
1 MGVTCVSQMP VAEGKSVQQT VELLTRKLEM LGAEKQGTFC VDCETYHTAA STLGSQGQTG
61 KLMYVMHNSE YPLSCFALFE NGPCLIADTN FDVLMVKLKG FFQSAKASKI ETRGTRYQYC
121 DFLVKVGTVT MGPSARGISV EVEYGPCVVA SDCWSLLLEF LQSFLGSHTP GAPAVFGNRH
181 DAVYGPADTM VQYMELFNKI RKQQQVPVAG IRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MED20 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- tongue: 15 nTPM
- skeletal muscle: 13 nTPM
- placenta: 13 nTPM
- epididymis: 12 nTPM
- tonsil: 12 nTPM
- kidney: 12 nTPM
Single-cell type
- distal convoluted tubule cells: 8.3 nCPM
- choroid plexus epithelial cells: 5.7 nCPM
- loop of henle epithelial cells: 5.7 nCPM
- oligodendrocyte progenitor cells: 4.8 nCPM
- renal collecting duct intercalated cells: 4.8 nCPM
- ependymal cells: 4.6 nCPM
Immune cell
- intermediate monocyte: 29 nTPM
- myeloid DC: 26 nTPM
- classical monocyte: 25 nTPM
- naive B-cell: 23 nTPM
- plasmacytoid DC: 23 nTPM
- non-classical monocyte: 21 nTPM
Brain region
- cerebellum: 18 nTPM
- choroid plexus: 18 nTPM
- white matter: 18 nTPM
- thalamus: 17 nTPM
- cerebral cortex: 16 nTPM
- hypothalamus: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0.3
- gnomAD missense Z
- 1.23
- DepMap mean gene effect
- -1.36
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA-templated transcription
- positive regulation of transcription elongation by RNA polymerase II
- positive regulation of transcription initiation by RNA polymerase II
- regulation of transcription by RNA polymerase II
- RNA polymerase II preinitiation complex assembly
- skeletal muscle cell differentiation
- transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Mediator complex, subunit Med20
- TATA-binding related factor (TRF) of subunit 20 of Mediator complex
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MED20 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MED20 as an antibody target. Whether an autoantibody or antibody against MED20 could matter depends on whether native MED20 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MED20 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MED20 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...